Clarity Medical Group Holding Ltd. has announced the receipt of a complaint letter alleging that the company potentially overstated its profits in its prospectus and failed to disclose certain dividend re-routing activities for remuneration purposes among shareholders and past medical practitioners. In response, the company's board has established a Separate Special Committee to investigate these allegations. The board has not yet formed a view on the truth or accuracy of these claims and will update shareholders and investors as the investigation progresses. Investors are advised to exercise caution when dealing with the company's shares.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。